Comparative Pharmacology
Head-to-head clinical analysis: KLEBCIL versus PENTIDS 200.
Peer-Reviewed Evidence
Head-to-head clinical analysis: KLEBCIL versus PENTIDS 200.
KLEBCIL vs PENTIDS '200'
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Klebcillin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidase activity, and activating autolytic enzymes.
Penicillin G is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), thereby inhibiting transpeptidation and activating autolytic enzymes.
KLEBCIL (ceftazidime-avibactam) 2.5 g (ceftazidime 2 g + avibactam 0.5 g) IV every 8 hours infused over 2 hours.
Penicillin G benzathine: 1.2 million units intramuscularly as a single dose.
None Documented
None Documented
2-3 hours (prolonged to 30-60 hours in severe renal impairment; adjust dosing)
0.5-1 hour; prolonged in renal impairment; anuric patients up to 10 hours
Primarily renal (70-80% unchanged); minor biliary/fecal (15-20%)
Renal: 60-90% unchanged; biliary/fecal: 10-40%
Category C
Category C
Penicillin Antibiotic
Penicillin Antibiotic